Researchers at IIT Hyderabad have developed an AI platform to diagnose brain tumours using MRI scans. The tool removes the need for invasive biopsies.
The platform, named RadGLO, extracts genetic insights from MRI images. Doctors can now plan personalized treatments for glioma patients without surgery. The study was published in Precision Oncology in October 2025.
The team also introduced RaSPr (Radiomic Survival Predictor). It sorts patients into high-risk and low-risk groups based on MRI features. Doctors can now predict tumour aggressiveness, treatment response, and survival outcomes faster and more safely.
RadGLO links MRI features to 20,000 genes, providing insights into the tumour’s molecular profile. Doctors upload scans, receive automated risk predictions, and access genetic correlations. The platform enables accurate, personalized treatment planning. The research team included Kavita Kundal, Dr. K. Divya Rani, Vinodini D, Dr. Neeraj Kumar, and Dr. Rahul Kumar.
